ARMP (Armata Pharmaceuticals) OCF Yield %: -9.89 (As of Jun. 25, 2026)

What is Armata Pharmaceuticals OCF Yield %?

Armata Pharmaceuticals ARMP -10.20% 22 OCF Yield % is -9.89 as of Jun. 25, 2026. GuruFocus rates ARMP with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 1,419 Biotechnology companies, Armata Pharmaceuticals ranks worse than 50.88% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Armata Pharmaceuticals's Trailing 12-Month Cash Flow from Operations is $-23.97 Mil, and Market Cap is $242.29 Mil. Therefore, Armata Pharmaceuticals's OCF Yield % for today is -9.89%.

The historical rank and industry rank for Armata Pharmaceuticals's OCF Yield % or its related term are showing as below:

ARMP' s OCF Yield % Range Over the Past 10 Years
Min: -894.52 Med: -64.91 Max: -8.68
Current: -9.89

During the past 13 years, the highest OCF Yield % of Armata Pharmaceuticals was -8.68%. The lowest was -894.52%. And the median was -64.91%.

ARMP's OCF Yield % is ranked worse than
50.88% of 1419 companies
in the Biotechnology industry
Industry Median: -8.46 vs ARMP: -9.89

Armata Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was %.

Armata Pharmaceuticals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Armata Pharmaceuticals OCF Yield % Related Terms

Armata Pharmaceuticals OCF Yield % Historical Data

* Premium members only.

The historical data trend for Armata Pharmaceuticals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Armata Pharmaceuticals OCF Yield % Chart

Armata Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Yield %

Get a 7-Day Free Trial

-15.87

-72.47

-40.52

-56.10

-11.26

Armata Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Yield %	Get a 7-Day Free Trial															-57.38	-41.94	-15.92	-11.67	-6.16

ARMP vs SRZN, ELDN, NAGE: OCF Yield % Comparison

For the Biotechnology subindustry, Armata Pharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Armata Pharmaceuticals OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Armata Pharmaceuticals's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Armata Pharmaceuticals's OCF Yield % falls into.

Save Embed

22GF Score

Armata Pharmaceuticals Inc ARMP

OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Armata Pharmaceuticals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Armata Pharmaceuticals's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %	=	Cash Flow from Operations	/	Market Cap
	=	-25.763	/	228.78668
	=	-11.26%

Armata Pharmaceuticals's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %	=	Cash Flow from Operations	*	Annualized Factor	/	Market Cap
	=	-5.782	*	4	/	375.2448
	=	-6.16%

Frequently Asked Questions Learn more about OCF Yield % →

What does a OCF Yield % of -9.89 mean?

Armata Pharmaceuticals (ARMP) has a OCF Yield % of -9.89 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Armata Pharmaceuticals and its competitors. According to the industry distribution chart, Armata Pharmaceuticals ranks #722 out of 1419 companies in the Biotechnology industry, placing it in the top 50.9%.

Is Armata Pharmaceuticals' OCF Yield % too high?

Armata Pharmaceuticals' current OCF Yield % is -9.89. Based on the distribution chart, Armata Pharmaceuticals ranks #722 out of 1419 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Armata Pharmaceuticals has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.

How does Armata Pharmaceuticals' OCF Yield % compare to SRZN and ELDN?

According to the Biotechnology industry distribution chart, Armata Pharmaceuticals ranks #722 out of 1419 companies for OCF Yield %. This places Armata Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Yield % for a Biotechnology company?

A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Yield % mean?

A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Armata Pharmaceuticals and its competitors. Armata Pharmaceuticals's current OCF Yield % is -9.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Armata Pharmaceuticals stock overvalued right now?

Armata Pharmaceuticals (ARMP) has a current OCF Yield % of -9.89. The current OCF Yield % is -9.89. Armata Pharmaceuticals' overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Yield % calculated?

OCF Yield % is calculated from a company's financial statements. For Armata Pharmaceuticals (ARMP), the current OCF Yield % is -9.89 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Armata Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies SRZN ELDN NAGE PRLD HUMA TENX ZNTL RZLT AVXL DMAC VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges TG1N:Germany

Address 5005 McConnell Avenue, Los Angeles, CA, USA, 90066

Website https://www.armatapharma.com

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

22GF Score

Get the complete analysis for ARMP

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.60

Price

View ARMP Analysis

See OCF Yield % data for all stocks →